Posted by Michael Wonder on 07 Jan 2016
EMA started the evaluation of Richter’s marketing authorisation application for biosimilar teriparatide
4 January 2016 - Gedeon Richter Plc. today announced that the EMA has accepted Richter's regulatory submission for the proposed biosimilar to Eli Lilly's Forteo (teriparatide).
For more detaails, go to: https://www.richter.hu/en-US/pressroom/press-release/Pages/press-releases/pr160104.aspx
